Enlivex Ltd. (ENLV)
NASDAQ: ENLV · Real-Time Price · USD
1.055
-0.055 (-4.95%)
Mar 24, 2026, 10:20 AM EDT - Market open
Enlivex Market Cap
Enlivex has a market cap or net worth of $25.17 million as of March 24, 2026. Its market cap has decreased by -3.81% in one year.
Market Cap
25.17M
Enterprise Value
8.98M
1-Year Change
-3.81%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since March 26, 2019, Enlivex's market cap has decreased from $101.63M to $25.17M, a decrease of -75.23%. That is a compound annual growth rate of -18.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 263.49M | 57.85% |
| Dec 31, 2025 | 166.93M | 548.82% |
| Dec 31, 2024 | 25.73M | -48.77% |
| Dec 29, 2023 | 50.22M | -30.73% |
| Dec 30, 2022 | 72.50M | -36.72% |
| Dec 31, 2021 | 114.57M | -5.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyperion DeFi | 26.48M |
| Cue Biopharma | 25.96M |
| Barinthus Biotherapeutics | 25.73M |
| NeuroSense Therapeutics | 25.15M |
| Neuphoria Therapeutics | 24.85M |
| Senti Biosciences | 24.19M |
| Vistagen Therapeutics | 24.13M |
| Passage Bio | 23.83M |